FDA to review rejected weight loss drug Qnexa - News-Medical.net
Mother Nature NetworkFDA to review rejected weight loss drug QnexaNews-Medical.netQnexa combines two currently approved drugs. One is the appetite suppressant phentermine, the safer "phen" part of the infamously unsafe fen-phen diet drug. The other half of Qnexa is the seizure/migraine drug topiramate. The topiramate label lists .Side Effects of Diet Pill Still Concern RegulatorsNew York TimesQnexa: A magic diet pill?Mother Nature NetworkFDA to Review New Diet DrugFirst Coast NewsCBS News -RedOrbit -MyFox Tampa Bayall 82 news articles »
FDA to review rejected weight loss drug Qnexa - News-Medical.net
US to Review Diet Treatment Once Rejected - New York Times
New York TimesUS to Review Diet Treatment Once RejectedNew York TimesNext week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's .Weight-Loss Drug Qnexa Under FDA Safety ReviewEveryday HealthDiet pill combo, already in use, sparks a second look by the FDASarasota Herald-TribuneFDA to review prescription diet pill it once rejectedSacramento BeeChicago Tribune -MyFox Los Angeles -Newserall 257 news articles »
US to Review Diet Treatment Once Rejected - New York Times
Drug with Los Osos link to get second FDA review - San Luis Obispo Tribune
Drug with Los Osos link to get second FDA reviewSan Luis Obispo TribuneBy Andrew Pollack The New York Times Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, .
Drug with Los Osos link to get second FDA review - San Luis Obispo Tribune
FDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects . - The Consumerist
The ConsumeristFDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects .The ConsumeristAfter rejecting the drug in 2010, the Food and Drug Administration will review Qnexa again Wednesday. The New York Times reports there is pressure on the FDA to green-light the drug because the medical community needs more ammunition to combat obesity.
FDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects . - The Consumerist
PRESS DIGEST - New York Times business news - Feb 17 - Reuters
PRESS DIGEST - New York Times business news - Feb 17ReutersNext week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's .and more »
PRESS DIGEST - New York Times business news - Feb 17 - Reuters
Mother Nature NetworkFDA to review rejected weight loss drug QnexaNews-Medical.netQnexa combines two currently approved drugs. One is the appetite suppressant phentermine, the safer "phen" part of the infamously unsafe fen-phen diet drug. The other half of Qnexa is the seizure/migraine drug topiramate. The topiramate label lists .Side Effects of Diet Pill Still Concern RegulatorsNew York TimesQnexa: A magic diet pill?Mother Nature NetworkFDA to Review New Diet DrugFirst Coast NewsCBS News -RedOrbit -MyFox Tampa Bayall 82 news articles »
FDA to review rejected weight loss drug Qnexa - News-Medical.net
US to Review Diet Treatment Once Rejected - New York Times
New York TimesUS to Review Diet Treatment Once RejectedNew York TimesNext week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's .Weight-Loss Drug Qnexa Under FDA Safety ReviewEveryday HealthDiet pill combo, already in use, sparks a second look by the FDASarasota Herald-TribuneFDA to review prescription diet pill it once rejectedSacramento BeeChicago Tribune -MyFox Los Angeles -Newserall 257 news articles »
US to Review Diet Treatment Once Rejected - New York Times
Drug with Los Osos link to get second FDA review - San Luis Obispo Tribune
Drug with Los Osos link to get second FDA reviewSan Luis Obispo TribuneBy Andrew Pollack The New York Times Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, .
Drug with Los Osos link to get second FDA review - San Luis Obispo Tribune
FDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects . - The Consumerist
The ConsumeristFDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects .The ConsumeristAfter rejecting the drug in 2010, the Food and Drug Administration will review Qnexa again Wednesday. The New York Times reports there is pressure on the FDA to green-light the drug because the medical community needs more ammunition to combat obesity.
FDA Will Give Another Look To Weight Loss Pill Said To Cause Birth Defects . - The Consumerist
PRESS DIGEST - New York Times business news - Feb 17 - Reuters
PRESS DIGEST - New York Times business news - Feb 17ReutersNext week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's .and more »
PRESS DIGEST - New York Times business news - Feb 17 - Reuters
Vivus's Qnexa - FDA Panel Analysis
News Update: Vivus Halted in Pre-Market Trade - FDA Panel to Consider Qnexa Diet Drug Today
